
UCSF Liver Center
@ucsflivercenter
The goal of the Liver Center is to integrate bench science with clinical investigation, in support of its vision to understand and cure human liver diseases.
ID: 1420848293068697601
https://livercenter.ucsf.edu/ 29-07-2021 20:47:11
47 Tweet
180 Takipçi
6 Takip Edilen

The UCSF Liver Center contingent is inspired by the great science at #LBCSRC22! If you agree, and are looking for a rewarding postdoc, please contact us! We are happy to discuss opportunities in a variety of liver labs.


Can extra #MELD points allocated based on height improve sex disparities in liver #transplant? Check out this 📝 by Bernard et al in American Journal of Transplantation to see! Summary below (by SoMe Jeremy Louissaint of UTSW Gastroenterology Fellowship) doi.org/10.1111/ajt.17… #LiverTwitter #equity #livertransplant

Congratulations to Monika Sarkar and colleagues from the UCSF Liver Center on their publication documenting an increased risk of NASH in women of reproductive age who have polycystic ovary syndrome. pubmed.ncbi.nlm.nih.gov/35861548/

Kudos to Amar Nijagal, Bruce Wang and Franklin Huang on their new pub demonstrating that single cells & organoids from pediatric hepatoblastomas reveal unique features that predict responses to chemotherapy. UCSF Liver Center UCSF Surgery UCSF Department of Medicine pubmed.ncbi.nlm.nih.gov/36008377/



Congratulations to Marko Groeger et al from the Willenbring lab, who report in a human iPSC model that inflammatory signaling from activated iPSC-macrophages induces insulin resistance in iPSC-hepatocytes. UCSF Surgery UCSF Broad Stem Cell UCSF Med Education pubmed.ncbi.nlm.nih.gov/37400454/

Latest from Arielle Klepper, Michele Tana and colleagues at the UCSF Liver Center: UCSF Med Education UCSF Gastroenterology Fellowship Chan Zuckerberg Biohub Network pubmed.ncbi.nlm.nih.gov/37398174/

‼️Monday, Nov 13th, in Boston, UCSF Transplant & UCSF Liver Center researcher, Dr. Holger Willenbring, takes the stage at AASLD Liver Meeting AASLD to give the Hans Popper State-of-the-Art Lecture, sharing his vision on the "Next Generation Human Liver Gene Therapy"👇


Congrats to Holger Willenbring with the Hans Popper award lecture #TLM2023 UCSF Liver Center


The FASEB Summer Liver Biology Conference you have grown to know and love has a new name - SLAM, the Summer Liver Academy Meeting! Save the date and spread the word for June 2024.👇 Website and program coming soon!🙌 AASLD EASL Education American Gastroenterological Association (AGA) American Society for Investigative Pathology #livertwitter



Check out the program and register for SLAM, the Summer Liver Academy Meeting! Looking forward to seeing you in June! 👉slam24.asip.org #livertwitter UCSF Liver Center


Just TWO MORE DAYS to save on registration for SLAM 2024! Register by March 31 slam24.asip.org #ASIPmeeting #liverresearch #liverdisease #livercancer UC San Francisco PittDeptofMed Novartis Science PLRC UCSF Liver Center


Thank you to the #SLAM2024 sponsors! AASLD PLRC The American Journal of Pathology American Society for Investigative Pathology Blue Faery Novartis UCSF Liver Center American Gastroenterological Association (AGA) #ASIPmeeting #liverresearch #liverdisease #livercancer


‼️Kicking off the week by revealing that UC San Francisco Pediatric Surgeon Dr. Amar Nijagal has been rewarded a $50,000 Pilot/Feasibility Grant from UCSF Liver Center for his study titled "Deciphering the Role of Macrophage Mediated Signals on Immune Tolerance in the Developing Liver."👏👏


‼️Tomorrow, Jan. 15th, at 7am - Transplant Surgeon Dr. Garrett Roll & Director of our UCSF Liver Center Dr. Holger Willenbring, will deliver their talk on "Machine Perfusion of the Liver: Clinical Impact and Discovery Potential" at Grand Rounds.. Join Us 👉ow.ly/y53R50JrV2R


Just published! 🎉New article using machine perfusion of non-transplantable human livers to optimize and de-risk liver gene therapy with AAV vectors. Facilitated by contributions from all UCSF Liver Center cores. See publication in Nature Biotechnology nature.com/articles/s4158…

Just published! 🎉Machine perfusion of non-transplantable human livers permits optimization and de-risking of liver gene therapy with AAV vectors. Funded by NIDDK with contributions from all UCSF Liver Center cores. See publication in Nature Biotechnology nature.com/articles/s4158…